Noom comes at this from the opposite direction to everyone else. The medication is the add-on to the programme, not the programme's reason for existing — and that shows in how it doses.
Noom Med's compounded offering is a Microdose GLP-1Rx programme at $179 a month, covering compounded semaglutide or tirzepatide, following a $49 introductory month.
The behavioural side is the genuine differentiator. Noom built the largest consumer behaviour-change programme in weight management, and for people whose difficulty is sustaining change rather than initiating it, that infrastructure is worth more than a $30 monthly price difference on a vial.
The microdosing question
Microdosing means using doses below the standard titration schedule. It is marketed for gentler side effects and lower cost, and both of those can be true. What it cannot claim is the efficacy evidence, because the trials that produced the well-known weight-loss figures used standard escalating doses.
That does not make it unreasonable. Some people cannot tolerate standard doses, and a lower dose that is taken beats a standard dose that is abandoned. But it should be a clinical decision made openly, not a pricing decision dressed as a clinical one.
Your muscle-protection numbers
Weight lost on a GLP-1 is not all fat. Protein intake and resistance training are the two levers with the best evidence behind them. Set your weight to see the targets.
Daily protein target
120–200 g
Roughly 30 g at each of four eating occasions gets you to the bottom of that range.
Resistance training
2–3 ×/week
Full-body sessions covering legs, push and pull. Loaded movement is the signal that tells your body to keep the muscle.
General nutrition and activity information, not medical advice. Protein targets can be inappropriate in kidney disease and some other conditions — check with your clinician before changing your intake.
What compounded semaglutide actually is
Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.
That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.
Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.
The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.